These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 18076066
1. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model. Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E, Toonen LW, Nierkens S, Adema GJ. Int J Cancer; 2008 Apr 15; 122(8):1794-802. PubMed ID: 18076066 [Abstract] [Full Text] [Related]
2. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Prins RM, Odesa SK, Liau LM. Cancer Res; 2003 Dec 01; 63(23):8487-91. PubMed ID: 14679014 [Abstract] [Full Text] [Related]
3. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response. Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H. Gene Ther; 2004 Nov 01; 11(21):1551-8. PubMed ID: 15343358 [Abstract] [Full Text] [Related]
5. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Cancer Res; 2004 Jul 15; 64(14):4973-9. PubMed ID: 15256471 [Abstract] [Full Text] [Related]
6. DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma. Maes W, Rosas GG, Verbinnen B, Boon L, De Vleeschouwer S, Ceuppens JL, Van Gool SW. Neuro Oncol; 2009 Oct 15; 11(5):529-42. PubMed ID: 19336528 [Abstract] [Full Text] [Related]
7. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. Tüting T, Steitz J, Brück J, Gambotto A, Steinbrink K, DeLeo AB, Robbins P, Knop J, Enk AH. J Gene Med; 1999 Oct 15; 1(6):400-6. PubMed ID: 10753065 [Abstract] [Full Text] [Related]
8. Antitumor efficacy of argon-helium cryoablation-generated dendritic cell vaccine in glioma. Yin Z, Lu G, Xiao Z, Liu T, He X, Wang Q, Lin C, Zhang S. Neuroreport; 2014 Mar 05; 25(4):199-204. PubMed ID: 24445619 [Abstract] [Full Text] [Related]
9. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma. Jiang XB, Lu XL, Hu P, Liu RE. Vaccine; 2009 Oct 19; 27(44):6210-6. PubMed ID: 19699331 [Abstract] [Full Text] [Related]
10. Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma. Sakai K, Shimodaira S, Maejima S, Udagawa N, Sano K, Higuchi Y, Koya T, Ochiai T, Koide M, Uehara S, Nakamura M, Sugiyama H, Yonemitsu Y, Okamoto M, Hongo K. J Neurosurg; 2015 Oct 19; 123(4):989-97. PubMed ID: 26252465 [Abstract] [Full Text] [Related]
11. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide. Lai C, Duan S, Ye F, Hou X, Li X, Zhao J, Yu X, Hu Z, Tang Z, Mo F, Yang X, Lu X. Theranostics; 2018 Oct 19; 8(6):1723-1739. PubMed ID: 29556352 [Abstract] [Full Text] [Related]
18. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas. Ni HT, Spellman SR, Jean WC, Hall WA, Low WC. J Neurooncol; 2001 Jan 19; 51(1):1-9. PubMed ID: 11349874 [Abstract] [Full Text] [Related]
19. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice. Bu N, Wu H, Zhang G, Zhan S, Zhang R, Sun H, Du Y, Yao L, Wang H. J Mol Neurosci; 2015 Jul 19; 56(3):631-43. PubMed ID: 25680514 [Abstract] [Full Text] [Related]